4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001628280-26-001263
Chief Executive Officer sold 47,506 shares at an average $1.98 ($94,176)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| OConnell Daniel Joseph Chief Executive Officer | 2026-01-05 | Sale | −4,649 | $1.97 | $9,163 | 662,839 | D |
| OConnell Daniel Joseph Chief Executive Officer | 2026-01-06 | Sale | −5,102 | $1.97 | $10,032 | 657,737 | D |
| OConnell Daniel Joseph Chief Executive Officer | 2026-01-07 | Sale | −37,755 | $1.99 | $74,981 | 619,982 | D |
| Open-market sales · 47,506 sh · avg $1.98 · $94,176 | |||||||
Loading xslF345X05/wk-form4_1767839464.xml…